Press release
CELL LINE DEVELOPMENT SERVICES MARKET TO WITNESS STEADY GROWTH IN THE COMING DECADE
Roots Analysis has announced the addition of “Cell Line Development Services Market, 2017-2027” report to its list of offerings. The report features an extensive study on the rapidly growing market of cell line development and manufacturing services providers. The report presents an elaborate compilation of research, analysis and opinions on several key aspects of the market.Akanksha Bhagtani, the principal analyst, said, “The growing pipeline of biological drugs has resulted in a continuous increase in the demand for different types of cell lines. Additionally, the loss of patent exclusivity of several biologics and the entry of numerous biosimilars, and need for cell lines in other areas, such as drug screening, gene functional studies, cell-based assay development, diagnostics and tissue engineering, have resulted in further increase in the demand for different types of cell lines. This presents significant opportunities to cell line development service providers.”
One of the primary objectives of the study was to project the growth of this market segment and evaluate the future prospects of upcoming cell line development technologies / services. Amongst other things, the study highlights the following:
• The current competitive market landscape with respect to key players, along with information on the location of their manufacturing facilities, distribution of cell lines based on their source of origin (mammalian, microbial, insect-derived, avian, marine and reptilian), type of cell lines (recombinant, hybridoma and primary cell lines), affiliated production technologies, purpose of production (R&D, diagnostics, biomanufacturing and tissue engineering), and other associated services (cell line characterization, cell banking, cell bank characterization, process development, cGMP manufacturing of biologics, fill / finish of end products and commercialization of reagents / equipments).
• A detailed analysis of the database presented as three schematic representations; a world map depicting the most active geographies in terms of the presence of cell line development facilities, a heat map representing the distribution of companies on the basis of their location (continent-wise distribution), year of establishment and cell line development capabilities, and a logo landscape highlighting the distribution of companies based on the number of employees and the source of cell lines.
• Elaborate profiles of key industry players that have proprietary technologies for the development of cell lines and offer other services, such as cell line characterization, cell banking and cGMP production of biologics, as well. Each profile features an overview of the company, its financial performance, information on cell line development services and proprietary technology, manufacturing facilities, expansions and collaborations, and a comprehensive future outlook.
• Detailed profiles of non-industry players (cell line repositories) that play an active role in the development of cell lines and offer affiliated services, as well. Each profile features an overview of the repository and a brief description of the cell line development services offered.
• An analysis of the future growth opportunity, segmented by regions, source and grade of cell lines. For the purposes of this analysis, several parameters, such as the number of companies involved, price of cell lines depending (characterized or uncharacterized), source of cell lines, and average number of cell line development projects undertaken by companies in a year, were taken into consideration.
Bhagtani further added, “Among different types of sources used to obtain cell lines, mammalian sources continue to be preferred (~80%); this is followed by microbial cell lines. Overall, the cell line development services market is poised to grow at a steady pace in the coming decade.”
The report highlights the contributions of several players in the field, including those that are listed below:
• Abzena
• Batavia Biosciences
• Celonic
• CMC Biologics
• Cobra Biologics
• Hyprocell
• LFB Biomanufacturing
• Lonza
• ProBioGen
• Selexis
• trenzyme
The opinions and insights discussed in this report were influenced by discussions conducted with industry experts. The report features detailed transcripts of interviews held with Fan Chen (Vice President Bioprocessing, LakePharma), Michael Pointek (Managing Director, Artes Biotechnology), Nienke Smits (Business Development, Modiquest) and Oscar Hoogteijling (Business Development Manager, Bioceros).
For additional details, please visit
https://www.rootsanalysis.com/reports/view_document/cell-line-development-services-market-2017-2027/171.html
or email sales@rootsanalysis.com
Roots Analysis is a specialist market research company, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you'd like us to help you with your growing business needs, get in touch at info@rootsanalysis.com
For additional details, please visit
https://www.rootsanalysis.com/reports/view_document/cell-line-development-services-market-2017-2027/171.html
or email sales@rootsanalysis.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release CELL LINE DEVELOPMENT SERVICES MARKET TO WITNESS STEADY GROWTH IN THE COMING DECADE here
News-ID: 984345 • Views: …
More Releases from Roots Analysis
Pharmacy Market Size to Hit USD 4.1 Tillion by 2035 | Exclusive Report by Roots …
The global pharmacy market, valued at USD 2.4 trillion in 2024, is estimated to reach USD 2.5 trillion in 2025 and USD 4.1 trillion by 2035, representing a CAGR of 5% during the forecast period.
The pharmacy market is broadly segmented on the basis of Market by Distribution by type of Pharmacy, Product Offered, Availability, Drug Molecule, Therapeutic Area and Key Geographical Regions.
Revolutionizing pharmacy industry: unleashing the power of technological advancements.…
Global targeted drug delivery device market is anticipated to reach to USD $2,15 …
The prevalence of chronic diseases has increased significantly over the past few decades. Presently, around 129 million people in the US have at least one life threating chronic condition, such as heart disease, cancer, diabetes, obesity or hypertension.
The global targeted drug delivery device market size is projected to grow from $427 Million in 2026 to $2,153 Million by 2035, representing a CAGR of 19.7% during the forecast period.
Additionally, about…
EMI shielding market Overview
Owing to the increasing reliant on electronic devices, the risk of electromagnetic interference (EMI) has grown. EMI occurs when electromagnetic waves generated by one device disrupt the operation of nearby electronic systems.
This interference can compromise device performance, reliability, and safety, making it a significant concern across various industries. To address this challenge, EMI shielding technologies have been developed. These involve the use of conductive or magnetic materials that either…
Biomanufacturing market is anticipated to reach to $12.0 billion by 2035with CAG …
Recognizing the potential of digitalization, biomanufacturers are increasingly adopting advanced platforms that enable operational excellence, enhance visibility, improve control, and synchronization across their bioprocessing operations
Biomanufacturing refers to a standardized process that utilizes microorganisms and other biological systems to produce and develop biomolecules as therapeutic modalities. Traditionally, the biopharmaceutical companies have hesitated to adopt cutting-edge digital technologies, such as cloud computing, artificial intelligence (AI), machine learning and internet of things (IoT),…